CFTR and cystic fibrosis: Modulator therapy may affect bone health of those with CF directly by increasing CFTR function in osteoblast formation and indirectly through improving nutritional status.(27) The majority of the future adult CF population will benefit from highly effective CFTR modulation, as now 90% of people with CF in the United States are eligible for HEMT.